Loading...

Fixation Buffer

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixative, Paraformaldehyde
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420801 100 mL 48€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Fixation Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.

Product Details
Technical data sheet

Product Details

Storage & Handling
This buffer solution should be stored between 2°C and 8°C.
Application

ICFC - Quality tested
ICC
Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
  3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
  4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
  5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations
  1. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  2. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  3. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  4. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  5. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  6. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  7. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  8. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  9. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  10. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  11. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  12. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  13. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  14. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  15. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  16. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  17. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  18. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  19. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  20. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  21. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  22. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  23. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  24. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  25. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  26. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  27. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  28. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  29. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  30. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  31. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  32. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  33. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  34. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  35. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  36. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  37. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  38. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  39. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  40. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  41. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  42. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  43. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  44. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  45. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  46. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  47. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  48. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  49. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  50. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  51. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  52. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  53. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  54. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  55. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  56. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  57. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  58. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  59. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  60. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  61. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  62. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  63. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  64. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  65. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  66. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  67. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  68. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  69. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  70. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  71. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  72. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  73. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  74. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  75. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  76. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  77. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  78. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  79. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  80. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  81. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  82. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  83. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  84. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  85. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  86. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  87. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  88. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  89. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  90. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  91. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  92. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  93. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  94. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  95. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  96. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  97. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  98. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  99. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  100. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  101. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  102. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  103. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  104. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  105. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  106. Ma K, et al. 2022. iScience. 25:104347. PubMed
  107. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  108. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  109. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  110. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  111. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  112. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  113. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  114. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  115. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  116. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  117. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  118. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  119. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  120. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  121. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  122. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  123. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  124. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  125. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  126. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  127. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  128. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  129. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  130. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  131. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  132. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  133. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  134. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  135. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  136. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  137. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  138. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  139. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  140. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  141. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  142. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  143. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  144. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  145. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  146. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  147. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  148. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  149. Wang X, et al. 2022. Elife. 11:. PubMed
  150. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  151. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  152. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  153. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  154. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  155. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  156. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  157. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  158. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  159. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  160. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  161. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  162. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA
Go To Top Version: 4    Revision Date: 07.25.2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account